ReviewCureus2026
Artificial Intelligence in Botulinum Toxin Injections: A Mini-Review of Current Applications, Challenges, and Translational Perspectives.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Botulinum toxin (BoNT) injection is widely used in aesthetic dermatology, plastic surgery, neurology, and rehabilitation, but treatment still depends on the clinician's experience, anatomical judgment, and iterative dose adjustment. Artificial intelligence (AI) may support BoNT practice through facial analysis, anatomical mapping, treatment simulation, response prediction, image-guided injection, and objective outcome assessment. Current evidence includes chatbot-assisted planning, deep learning analysis of facial expression, magnetic resonance imaging-based prediction of dystonia response, multimodal machine learning for spasticity, computational diffusion modeling, and AI-assisted ultrasound interpretation. This mini review, based on PubMed-indexed and related peer-reviewed literature, summarizes representative AI applications across the BoNT treatment pathway and emphasizes a cautious clinical framework in which AI supports, but does not replace, physician judgment. Evidence remains preliminary and heterogeneous, with limitations related to small sample sizes, retrospective designs, and limited external validation. However, this mini-review synthesizes the most recent and relevant high-quality studies and provides a timely, structured overview of emerging AI applications to support clinical decision-making in BoNT practice. Future translation should prioritize prospective validation, formulation-aware dose modeling, transparent governance, and physician-supervised implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.